Cargando…

Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective Study

Multidrug-resistant (MDR) organisms are emerging as some of the main healthcare problems worldwide. During the COVID-19 pandemic, several Infection Prevention and Control (IPC) measures have been adopted to reduce nosocomial microorganism transmission. We performed a case–control study to identify i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bentivegna, Enrico, Luciani, Michelangelo, Arcari, Luca, Santino, Iolanda, Simmaco, Maurizio, Martelletti, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908142/ https://www.ncbi.nlm.nih.gov/pubmed/33498701 http://dx.doi.org/10.3390/ijerph18031003

Ejemplares similares

Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection
por: Bentivegna, Enrico, et al.
Publicado: (2021)

Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate
por: Martelletti, Paolo, et al.
Publicado: (2020)

No Evidence of SARS-CoV-2 Circulation in Rome (Italy) during the Pre-Pandemic Period: Results of a Retrospective Surveillance
por: Capalbo, Carlo, et al.
Publicado: (2020)

Long-COVID Headache
por: Martelletti, Paolo, et al.
Publicado: (2021)

The Point-of-Care Ultrasound (POCUS) by the Handheld Ultrasound Devices (HUDs) in the COVID-19 Scenario: a Review of the Literature
por: Martocchia, Antonio, et al.
Publicado: (2022)

Unmet Needs in Preventive Treatment of Migraine
por: Bentivegna, Enrico, et al.
Publicado: (2023)

OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity
por: Onan, Dilara, et al.
Publicado: (2022)

Multidrug resistance (mdr) genes in human cancer.
por: Nooter, K., et al.
Publicado: (1991)

Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China
por: Sun, Yanni, et al.
Publicado: (2015)

The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
por: Wolfensberger, Aline, et al.
Publicado: (2019)

Access to COVID-19 Vaccination during the Pandemic in the Informal Settlements of Rome
por: Bentivegna, Enrico, et al.
Publicado: (2022)

Validation of a small-size pooling approach targeting hospital surveillance of SARS-CoV-2 infection
por: Petrucca, Andrea, et al.
Publicado: (2020)

Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Guérin (BCG): Case Report
por: Luciani, Michelangelo, et al.
Publicado: (2020)

Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925
por: Yang, X, et al.
Publicado: (2014)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
por: Ali, Monadil H., et al.
Publicado: (2019)

Optimising migraine treatment: from drug-drug interactions to personalized medicine
por: Pomes, Leda Marina, et al.
Publicado: (2019)

SARS-CoV-2 Transmission Control Measures in the Emergency Department: The Role of Rapid Antigenic Testing in Asymptomatic Subjects
por: Borro, Marina, et al.
Publicado: (2022)

Novel Migraine Therapies May Reduce Public and Personal Disadvantages for People with Migraine
por: Ambat, Fidel Dominique Festin, et al.
Publicado: (2022)

Extremely Severe Case of COVID-19 Pneumonia Recovered Despite Bad Prognostic Indicators: a Didactic Report
por: Bentivegna, Enrico, et al.
Publicado: (2020)

Structural and Functional Brain Changes in Migraine
por: Ashina, Sait, et al.
Publicado: (2021)

Regulation and expression of multidrug resistance (MDR) transcripts in the intestinal epithelium
por: Li, M, et al.
Publicado: (1999)

Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
por: Wang, Jinglu, et al.
Publicado: (2017)

Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies
por: Catalano, Alessia, et al.
Publicado: (2022)

Lessons Learned from the Lessons Learned in Public Health during the First Years of COVID-19 Pandemic
por: Marcassoli, Alessia, et al.
Publicado: (2023)

Mercuric-sulphide based metallopharmaceutical formulation as an alternative therapeutic to combat viral and multidrug-resistant (MDR) bacterial infections
por: Malarvizhi, Kootharasan, et al.
Publicado: (2023)

Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents
por: Feng, Senling, et al.
Publicado: (2020)

Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids
por: Limtrakul, Pornngarm, et al.
Publicado: (2004)

Functional Evidence of Multidrug Resistance Transporters (MDR) in Rodent Olfactory Epithelium
por: Molinas, Adrien, et al.
Publicado: (2012)

Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer
por: Reis, Mariana Alves, et al.
Publicado: (2020)

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
por: Sabur, Natasha F., et al.
Publicado: (2021)

Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) Acinetobacter baumannii
por: Kumar, Sunil, et al.
Publicado: (2021)

A Case of Multidrug-Resistant (MDR) Tuberculosis and HIV Co-Infection
por: Vila Torres, Sebastian G, et al.
Publicado: (2023)

Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine
por: Gentile, Giovanna, et al.
Publicado: (2010)

Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine
por: Gentile, Giovanna, et al.
Publicado: (2010)

Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?
Publicado: (1996)

The Exponential Phase of the Covid-19 Pandemic in Central Italy: An Integrated Care Pathway
por: Capalbo, Carlo, et al.
Publicado: (2020)

Whole Genome Sequencing and Characterization of Multidrug-Resistant (MDR) Bacterial Strains Isolated From a Norwegian University Campus Pond
por: Finton, Misti D., et al.
Publicado: (2020)

Cross-talk between signalling pathways and the multidrug resistant protein MDR-1
por: Ding, S, et al.
Publicado: (2001)

Activity of Cefepime-Zidebactam against Multidrug-Resistant (MDR) Gram-Negative Pathogens
por: Thomson, Kenneth S., et al.
Publicado: (2019)

Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali()
por: Baya, Bocar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1sg2qgokscg0mmri31ugp99336